RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Bernard Arulanandam to Immunoglobulin G

This is a "connection" page, showing publications Bernard Arulanandam has written about Immunoglobulin G.
Connection Strength

0.533
  1. Goyins KA, Yu JJ, Papp SB, Beddard R, Murthy AK, Chambers JP, Arulanandam BP. Isotyping and quantitation of the humoral immune response to SARS-CoV-2. Exp Biol Med (Maywood). 2022 06; 247(12):1055-1060.
    View in: PubMed
    Score: 0.189
  2. Wali S, Gupta R, Yu JJ, Lanka GKK, Chambers JP, Guentzel MN, Zhong G, Murthy AK, Arulanandam BP. Chlamydial protease-like activity factor mediated protection against C. trachomatis in guinea pigs. Immunol Cell Biol. 2017 05; 95(5):454-460.
    View in: PubMed
    Score: 0.131
  3. Murthy AK, Cong Y, Murphey C, Guentzel MN, Forsthuber TG, Zhong G, Arulanandam BP. Chlamydial protease-like activity factor induces protective immunity against genital chlamydial infection in transgenic mice that express the human HLA-DR4 allele. Infect Immun. 2006 Dec; 74(12):6722-9.
    View in: PubMed
    Score: 0.065
  4. Arulanandam BP, O'Toole M, Metzger DW. Intranasal interleukin-12 is a powerful adjuvant for protective mucosal immunity. J Infect Dis. 1999 Oct; 180(4):940-9.
    View in: PubMed
    Score: 0.040
  5. Arulanandam BP, Van Cleave VH, Metzger DW. IL-12 is a potent neonatal vaccine adjuvant. Eur J Immunol. 1999 01; 29(1):256-64.
    View in: PubMed
    Score: 0.038
  6. Tang L, Yang Z, Zhang H, Zhou Z, Arulanandam B, Baseman J, Zhong G. Induction of protective immunity against Chlamydia muridarum intracervical infection in DBA/1j mice. Vaccine. 2014 Mar 10; 32(12):1407-13.
    View in: PubMed
    Score: 0.026
  7. Huber VC, Arulanandam BP, Arnaboldi PM, Elmore MK, Sheehan CE, Kallakury BV, Metzger DW. Delivery of IL-12 intranasally leads to reduced IL-12-mediated toxicity. Int Immunopharmacol. 2003 Jun; 3(6):801-9.
    View in: PubMed
    Score: 0.013
  8. Refici ML, Metzger DW, Arulanandam BP, Lennartz MR, Loegering DJ. Fcgamma-receptor signaling augments the LPS-stimulated increase in serum tumor necrosis factor-alpha levels. Am J Physiol Regul Integr Comp Physiol. 2001 Apr; 280(4):R1037-44.
    View in: PubMed
    Score: 0.011
  9. Buchanan RM, Briles DE, Arulanandam BP, Westerink MA, Raeder RH, Metzger DW. IL-12-mediated increases in protection elicited by pneumococcal and meningococcal conjugate vaccines. Vaccine. 2001 Feb 28; 19(15-16):2020-8.
    View in: PubMed
    Score: 0.011
  10. Buchanan RM, Arulanandam BP, Metzger DW. IL-12 enhances antibody responses to T-independent polysaccharide vaccines in the absence of T and NK cells. J Immunol. 1998 Nov 15; 161(10):5525-33.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support